Scrip
Questions linger over US comparative effectiveness funding
24 February 2009
Sue Sutter
24 February 2009
Sue Sutter
The economic stimulus bill signed into law by US President Barack Obama on February 17th provides a $1.1 billion bolus to government agencies for comparative effectiveness research on medical products, including pharmaceuticals. However, the legislation, and its lack of specificity...
Please Login to read the full article.
RELATED CONTENT
NEWS
- US groups outline comparative effectiveness research priorities
- PhRMA coalition's healthcare savings cannot be estimated, says US budget office
- Obama's nominee for HHS calls healthcare reform her "mission"
- Say goodbye to summer: US Congress returns for renewed battle on healthcare reform
EVENTS
22 March 2010
London, UK
12 April 2010
Orlando, Florida
13 April 2010
London, UK
JOB OF THE WEEK
Promote your vacancy here
DIRECTORY
Scrip Directory 2009
